Opus Genetics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $3,079 | $2,882 | $4,370 | $4,302 |
Gross Profit | 3,066 | -3,140 | 4,370 | -3,476 |
EBITDA | -17,373 | -8,892 | -6,809 | -10,026 |
EBIT | -17,386 | -8,906 | -6,822 | -10,029 |
Net Income | -17,454 | -7,420 | -8,194 | -35,135 |
Net Change In Cash | 3,079 | 2,882 | 4,370 | 4,302 |
Free Cash Flow | -6,157 | -10,269 | -8,994 | -7,438 |
Cash | 30,815 | 32,429 | 41,792 | 30,321 |
Basic Shares | 70,636 | 63,376 | 33,884 | 31,574 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,992 | $19,049 | $39,850 | $589 |
Gross Profit | 10,992 | 19,049 | 39,850 | 589 |
EBITDA | -57,522 | -9,968 | 18,216 | -56,687 |
EBIT | -57,532 | -9,974 | 18,212 | -56,691 |
Net Income | -57,532 | -9,986 | 17,888 | -56,693 |
Net Change In Cash | 10,992 | 19,049 | 39,850 | 589 |
Free Cash Flow | -25,576 | -1,112 | 14,314 | -19,370 |
Cash | 30,321 | 50,501 | 42,634 | 24,534 |
Basic Shares | 26,715 | 21,589 | 20,597 | 14,852 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | -$0.25 |
2025-06-30 | -$0.12 |
